Prognostic markers of disease recurrence in liver transplant recipients with hepatocellular carcinoma Ghent University
The present invention relates to the technical field of predicting recurrence of hepatocellular carcinoma (HCC) after liver transplantation. The present invention indeed discloses a set of biomarkers present in a serum sample taken from a HCC patient before liver transplantation which can be used to assess recurrence of HCC after liver transplantation. More specifically, the present invention discloses a process to predict the recurrence of HCC after liver transplantation via determining the amount of at least four specific N-glycans in a serum sample.